Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
Acq. announced
Elanco Animal Health Inc (ELAN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Elanco Announces Corporate Governance Enhancements"
08/07/2023 8-K Quarterly results
Docs: "RECEIVABLES LOAN AGREEMENT",
"Elanco Animal Health Reports Second Quarter 2023 Results and Raises Full Year Guidance"
07/13/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Environmental Protection Agency Completes Review of Seresto Collar and Confirms Continued Registration; Data Affirms Safety Profile of the Product",
"Summary of Seresto Stewardship Program issued by the Company on July 13, 2023"
07/10/2023 8-K Other Events  Interactive Data
05/09/2023 8-K Quarterly results
Docs: "Elanco Animal Health Reports First Quarter 2023 Results"
03/01/2023 8-K/A Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Financial Tables Reflecting Revisions to Previously Reported Financial Results"
01/31/2023 8-K Other Events  Interactive Data
01/09/2023 8-K Investor presentation
Docs: "© 2023 Elanco or its affiliates This presentation contains forward - looking statements within the meaning of Section 27A of the Securities Act of 1933 and Sectio n 21E of the Securities Exchange Act of 1934 , including, without limitation , our long - term revenue and earnings growth expectations, reduction of debt and leverage, expectations regarding product launche s and related regulatory proceedings, and our industry and our operations, performance, and financial condition . Forward - looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward - looking statements relate to the fu ture, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that a..."
11/08/2022 8-K Quarterly results
Docs: "Elanco Animal Health Reports Third Quarter 2022 Results"
09/08/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Elanco Announces Changes to its Board of Directors"
08/08/2022 8-K Quarterly results
06/29/2022 8-K Quarterly results
05/19/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
04/20/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Incremental Assumption Agreement by and among Elanco Animal Health Incorporated, Elanco US Inc., the subsidiary loan parties party thereto, Farm Credit Mid-America, PCA, as incremental term lender, and Goldman Sachs Bank USA, as the term facility agent"
04/13/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology",
"Elanco Animal Health Incorporated Announces Early Results of Tender Offer and Increase in Tender Cap for 2023 Notes"
03/29/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Elanco Animal Health Incorporated Announces Tender Offer for 2023 Notes"
02/24/2022 8-K Quarterly results
01/14/2022 8-K Other Events  Interactive Data
01/10/2022 8-K Investor presentation
Docs: "Investor Presentation of Elanco Animal Health Incorporated"
01/06/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/30/2021 8-K Cost Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits &nbs...
Docs: "Elanco Announces Changes to Simplify Organizational Structure, Drive Profitable Growth and Focus Investments on Growth and Innovation Opportunities"
11/05/2021 8-K Quarterly results
Docs: "Elanco Animal Health Reports Third Quarter 2021 Results Exceeding Revenue Guidance; Raising Full Year 2021 Revenue Guidance"
10/05/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Elanco Announces New Innovation Leader, Additional Strategic Move to Increase Focus on High-Value, Late-Stage Pet Health Pipeline Progress"
08/30/2021 8-K Quarterly results
08/12/2021 8-K Quarterly results
08/09/2021 8-K Quarterly results
08/02/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
07/01/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER"
06/16/2021 8-K Quarterly results
06/09/2021 8-K Quarterly results
06/04/2021 8-K Quarterly results
05/21/2021 8-K Quarterly results
05/07/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy